Forefront Wealth Management’s AbbVie ABBV Stock Holding History

Forefront Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$413K	Hold	1,809	–	–	0.3%	45
2025 Q3	$419K	Hold	1,809	–	–	0.31%	45
2025 Q2	$336K	Sell	1,809 -19	-1%	-$3.53K	0.27%	42
2025 Q1	$383K	Hold	1,828	–	–	0.35%	39
2024 Q4	$325K	Buy	+1,828	New	+$336K	0.3%	39
2023 Q3	$3.01M	Sell	20,203 -45	-0.2%	-$6.61K	4.22%	7
2023 Q2	$2.73M	Sell	20,248 -1,090	-5%	-$160K	3.61%	9
2023 Q1	$3.4M	Buy	21,338 +49	+0.2%	+$7.49K	4.45%	6
2022 Q4	$3.44M	Sell	21,289 -267	-1%	-$40.9K	4.63%	6
2022 Q3	$2.89M	Buy	21,556 +5,846	+37%	+$839K	4.03%	7
2022 Q2	$2.4M	Buy	15,710 +13,259	+541%	+$2.03M	3.24%	11
2022 Q1	$397K	Buy	2,451 +450	+22%	+$65.4K	0.39%	37
2021 Q4	$271K	Buy	+2,001	New	+$236K	0.26%	42

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Forefront Wealth Management's ABBV Position: Q4 2025 in Review

Forefront Wealth Management held its AbbVie (ABBV) position steady in Q4 2025 at 1,809 shares worth $413K. The position accounts for 0.3% of the portfolio, ranked #45.

Forefront Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 13 quarters since. The position peaked at $3.44M in Q4 2022. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Forefront Wealth Management held 1,809 shares of AbbVie worth $413K as of Q4 2025.
Forefront Wealth Management left its AbbVie share count unchanged in Q4 2025.
AbbVie made up 0.3% of Forefront Wealth Management's portfolio in Q4 2025, its #45 holding.
Forefront Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 13 quarters since.
Forefront Wealth Management's AbbVie position peaked at $3.44M in Q4 2022.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Forefront Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.